Screening & diagnostics

1.4.6 Screening for high risk individuals

The primary benefit of screening in high risk individuals is the potential for early intervention, when a condition is more treatable or even preventable. By focusing on specific populations—such as those with a family history, genetic predisposition, or certain lifestyle risk factors—healthcare systems can allocate resources more effectively and avoid unnecessary testing in the general population. A key challenge is the risk of false-positive results, which can lead to significant patient anxiety, over-diagnosis, and potentially harmful follow-up procedures, as well as the financial burden on the health system or to the consumer.

Obesity Screening for Children

One of the most widely implemented high-risk screening programs focuses on obesity in children and adolescents. Rather than a one-time check, this is a continuous process that involves routine measurement of a child’s height and weight to calculate their Body Mass Index (BMI). Early identification allows healthcare providers to educate families on nutrition and physical activity, offering timely behavioral and lifestyle interventions before the condition progresses into a more serious and difficult-to-manage state. This preventative screening is a powerful tool in combating the global rise of childhood obesity.

Mental Health Screening

Mental health screening is particularly crucial for groups with a known higher prevalence of mental illness, such as adolescents, individuals with a family history of a mood disorder, or those who have experienced significant trauma or loss. Screening tools, often in the form of questionnaires, can help to identify early signs of conditions like depression, anxiety disorders, and suicidal ideation. The benefit is that early identification can facilitate prompt access to counseling, therapy, or medication, improving outcomes and preventing a crisis. While there is no universal screening protocol, many healthcare systems and schools have adopted these targeted approaches to ensure that vulnerable individuals receive the support they need.

Allergy Screening

Allergy screening is specifically recommended for individuals with a family history of severe allergies or those who have experienced a prior allergic reaction to food, medications, or environmental triggers.

Genetic Screening

Genetic screening in the clinical setting is used to those with a higher risk of conditions or of passing on a specific inherited condition, such as cystic fibrosis or Huntington’s disease, to their children.

Cancer: Detection of the BRCA mutation for breast cancer, which not only alters risk, but the screening and management of the disease, was one of the earliest clinical use-cases for genetic information. In cervical cancer, the identification of specific genetic polymorphisms linked to cervical cancer susceptibility, can facilitate more personalized screening and preventive measures.

Huntington’s disease (HD): is a critical condition where genetic information plays a central role, impacting treatment decisions and prognostic assessments. Genetic information can inform both diagnosis and the timing of potential therapeutic interventions.

Genetic screening for prevention and other uses is discussed in further detail in the Innovation in Prevention section.